The early events involved in the host response to M. tuberculosis infection in the lung are still poorly understood. This paper sheds light into the initial mechanisms of infection by demonstrating that mycolic acid negatively modulates the alveolar epithelial cell response mediated by TLR2, suggesting that differences in the mycolic acid content in the M. tuberculosis cell wall may contribute to the fate of infection. 
Introduction
Mycobacterium tuberculosis is a leading infectious cause of death in adults worldwide (WHO, 2009) . Most often, the initial site of infection in lungs of someone exposed to M. tuberculosis inhaled in droplets released from an index case of tuberculosis is the alveolar air space. Most studies that examine host innate immune response to M. tuberculosis have focused on the effector functions of alveolar macrophages and dendritic cells (Tailleux et al., 2003; Herrmann & Lagrange, 2005; Wolf et al., 2007; Ehlers, 2010) . Mycobacterium tuberculosis has been shown to activate alveolar macrophages in a TLR-2-and TLR-4-dependent manner (Means et al., 2001) , and several lines of evidence suggest the innate immunity-mediated protective role of TLR-2 in mycobacterial infections (Fulton et al., 2004; Pai et al., 2004; Scanga et al., 2004; Harding & Boom, 2010) . However, these events that involve alveolar professional phagocytes most likely occur many days or weeks after the initial entry M. tuberculosis into the alveolar space.
The alveolar space is mostly composed of type I and type II pneumocytes. The former comprises about 96% of the alveolar surface area, while type II cells cover about 4% of the surface area but comprise 60% of all the alveolar epithelial cells (Castranova et al., 1988) . Thus, the inhaled tubercle bacilli most likely encounter these epithelial cells first before they can be taken up by alveolar macrophages and dendritic cells. A number of groups have recently begun to address the active involvement of alveolar epithelial cells in the early innate host defense against M. tuberculosis (Bermudez et al., 2002; Roy et al., 2004; Kohwiwattanagun et al., 2007; Rivas-Santiago et al., 2008a, b; Torrelles et al., 2008; Lee et al., 2009) .
In the 1950s, Segal and Bloch showed that M. tuberculosis isolated from mouse lungs use fatty acids to stimulate respiration instead of carbohydrates used by the organism grown in liquid cultures (Segal & Bloch, 1957) . Thus, during transmission, the tubercle bacilli in droplets released from a patient with tuberculosis are likely to be comprised of a population of cells in different metabolic states representing those in the lung lesions. Thus, another important factor that could determine the outcome of a new infection is the relative proportions of bacterial cells in different metabolic states at the time of transmission.
We previously demonstrated that an M. tuberculosis strain disrupted in a 13-gene operon called the mce1 (Δmce1) fails to induce a characteristic pro-inflammatory response in mice or ex vivo-infected murine macrophages (Shimono et al., 2003) . The mce1 operon is a member of a family of four related operons (mce1-4) that have been suggested by phylogenomic analyses to encode ABC transporters . Pandey and Sassetti have proposed that the mce4 operon encodes a possible cholesterol importer (Pandey & Sassetti, 2008) . de la Paz Santangelo et al. (2009) have suggested that the mce3 operon is a regulon involved in lipid metabolism of M. tuberculosis. Dunphy et al. (2010) showed that the mce1 operon may be involved in recycling mycolic acids released from dying bacteria during latent infection. They found that a functional disruption of fatty acyl-CoA synthetase encoded by fadD5 in the mce1 operon caused the mutant to be diminished in its growth in minimum medium supplied only with mycolic acid as a carbon source (Dunphy et al., 2010) .
The mce1 operon mutant is hypervirulent in BABL/c and C57BL/6 mice (Shimono et al., 2003; Lima et al., 2007) . It causes early death and induces poorly formed granulomas in mouse lungs with aberrant migration of inflammatory cells, resembling a Th2-type immune response (Shimono et al., 2003) . Mouse peritoneal macrophages or RAW cells infected ex vivo with the mutant expressed significantly lower levels of TNFa, IL-6, and MCP-1, compared with the cells infected with the wild-type strain (Shimono et al., 2003) . Interestingly, the cell wall of M. tuberculosis disrupted in the mce1 operon contains more than 10-fold greater amounts of mycolic acids than that of wild-type M. tuberculosis (Cantrell et al., 2013) . Moreover, the excess mycolic acids in the mutant are not covalently linked to these fatty acids' canonical substrates arabinogalactan or trehalose (Barry et al., 1998; Cantrell et al., 2013) .
We have shown that the mce1 operon is repressed in wild-type H37Rv M. tuberculosis during the first 4 weeks of infection in mice (Uchida et al., 2007) . That is, the wild-type strain behaves like the mce1 operon mutant at one phase of infection in vivo and that in lung lesions, a proportion of the bacterial population may indeed be comprised of cells that express free mycolic acids in their cell wall. This mixed population of cells in expectorated droplets is what is likely to be transmitted to a new host. Here, we propose that the ultimate fate of a new infection in the lungs is determined by the relative proportion of bacterial cells expressing and not expressing free mycolic acids during their initial encounter with alveolar epithelial cells. To address this hypothesis, we compared the interaction of M. tuberculosis and its mce1 operon mutant with A549 epithelial and RAW 264.7 macrophage cells.
Materials and methods

Bacterial strains and growth conditions
Wild-type M. tuberculosis H37Rv, its derivative mce1 operon mutant strain (Δmce1), and the complemented mce1 strain were grown in Middlebrook 7H9 broth (Difco Laboratories, MI) containing 10% albumin-dextrose-catalase (ADC) enrichment (Beckton-Dickinson, MD), supplemented with 0.2% glycerol (Fisher Scientific, NJ), and 0.05% Tween 80 (Fischer Scientific; 7H9-ADCT) in sterile, vented tissue culture flasks at 37°C in 5% CO 2 . We also examined an M. tuberculosis strain disrupted in the negative transcriptional regulator (mce1R) of the mce1 operon (Casali et al., 2006) . The construction of Dmce1, Dmce1R and their phenotype is previously reported (Shimono et al., 2003; Casali et al., 2006) . Bacterial strains were grown until the optical density (OD 580 nm ) of the cultures reached 1 (unless otherwise stated). When necessary, the above bacterial strains were also grown on solid agar medium Middlebrook 7H11 containing OADC (Beckton-Dickinson), 0.5% glycerol, and 100 lg mL À1 of antifungal agent cycloheximide (Sigma, MO).
Single-cell suspensions
Single-cell suspensions of each M. tuberculosis strain were prepared according to a previously described method (Grover et al., 1967) and quantified by enumeration of their colony-forming units (CFUs) on solid agar medium. Briefly, a 1.0 mL aliquot of a frozen mycobacterial culture (frozen at OD 580 nm = 1.0) was used to inoculate 30 mL of sterile Middlebrook 7H9-ADCT in a 75 cm 2 vented tissue culture flask. The 30 mL culture was incubated at 37°C in the presence of 5% CO 2 . After the culture was grown to OD 580 nm = 1.0, 10 mL of the culture was placed in a sterile 50 mL polypropylene tube and centrifuged at 3337 g for 15 min. The supernatant was discarded, and the pellet was suspended in 5 mL of RPMI 1640 cell culture media containing 5% fetal bovine serum (FBS; Omega Scientific, CA). The suspension was mixed thoroughly by pipetting and vortexing to dissociate clumped bacteria. The 5 mL suspension was then passed through a sterile 5.0 lm pore Acrodisc syringe filter (Pall Corp., MI) with a sterile 5 mL syringe. The resulting filtrate (single-cell suspension) was mixed by vortexing.
Maintenance and infection of alveolar epithelial cells
The human alveolar epithelial cell line A549 (ATCC CCL-185) was cultured and maintained in RPMI 1640 medium with 2 mM L-glutamine (Gibco, NY), supplemented with 10% heat-inactivated FBS, in a 5% CO 2 humidified incubator at 37°C. Cell concentration was determined with a hemocytometer. Cells were seeded at 10 5 cells per well in 12-well tissue culture plates and incubated overnight until the cells were c. 70% confluent. Immediately before infection, the medium was replaced with fresh and prewarmed RPMI 1640 medium with 5% FBS. A549 cells were always infected in triplicate with a multiplicity of infection (MOI) of 1 : 50 (cells: bacteria). Six hours after the infection, extracellular bacteria were removed by washing cells three times with warm RPMI 1640 5% FBS. After the third wash, RPMI 1640 5% FBS used to wash the cells was plated on solid medium to assess the presence or absence of extracellular bacteria. Infected monolayers were then incubated for 6, 24, 48, and 72 h at 37°C in a 5% CO 2 atmosphere. Uninfected cells served as negative controls for each experiment.
Enumeration of intracellular bacteria
At different time points after infection, the supernatants were removed, and A549 cells were lysed to enumerate the intracellular bacterial load. The infected cells were lysed by incubation with 0.5 mL of 0.1% Triton X-100 (Sigma) in sterile water for 20 min at room temperature. The resulting cell lysates were serially diluted and plated in triplicate on solid medium. Three weeks after plating, CFUs were enumerated.
Enzyme-linked immunosorbent assays (ELISA)
Infected (with M. tuberculosis or its derivative strains) or uninfected (negative control) A549 cells were incubated for up to 72 h. Supernatants were harvested at 6, 24, 48, and 72 h postinfection and sterilized by passing through a 0.2 lm Acrodisc PF filter (Gelman Sciences, MI). Chemokine concentrations in supernatants were measured by ELISA, according to the manufacturer's protocol (R&D Systems, MN). OD readings were obtained with a microplate reader model 450. Cytokines in the supernatants were quantified against the OD values obtained for the cytokine standards provided by the kit (R&D Systems). All cytokine quantification experiments were performed in triplicate.
Anti-TLR-2 antibody pretreatment and infection of alveolar epithelial cells
One set of A549 cells was treated with a mouse anti-human TLR-2 blocking antibody (clone T2.1; eBioscience, CA). After adding 10 lg mL À1 of antibodies, cells were incubated at room temperature for 30 min, as previously described (Asai et al., 2003) . The second set of A549 cells was exposed to the same conditions, except for the addition of the TLR-2 blocking antibody. Following incubation, cells were washed three times with prewarmed RPMI 1640 medium and infected with the bacterial strains at an MOI of 1 : 50 (cells/bacteria). Six hours after the infection, extracellular bacteria were removed by washing cells three times with warm RPMI 1640 5% FBS. After the third wash, RPMI 1640 5% FBS used to wash the cells was plated on solid medium to assess the presence or absence of extracellular bacteria. Infected monolayers were then incubated for 72 h at 37°C in a 5% CO 2 atmosphere. Uninfected cells served as negative controls for both set of cells. As a positive control, cells from each set were incubated for 72 h with 1 lg mL À1 of synthetic TLR-2 agonist Pam 3 Cys-Ser-(Lys) 4 (Pam 3 Cys; Sigma, CO). All experiments were performed in triplicate.
Pretreatment of alveolar epithelial cell line with mycolic acids and stimulation with TLR-2 agonist
Mycolic acids extracted from a clinical strain of M. tuberculosis were purchased from Sigma-Aldrich, CO. Lyophilized mycolic acids were resuspended in sterile DMSO (Sigma-Aldrich) to a concentration of 5 mg mL À1 . Cells were pre-incubated with either varying amounts of mycolic acids (125, 50, 25 ng mL À1 ) or without any mycolic acids at room temperature for 30 min. After the pre-incubation, cells were washed three times with prewarmed RPMI 1640 medium to remove excess mycolic acids. Washed cells were incubated with 1 lg mL À1 of TLR-2 agonist Pam 3 Cys (Sigma) for 72 h. These doses of mycolic acids and Pam 3 Cys were established in pilot dose-response studies. The ability of mycolic acids to block TLR-2-induced IL-8 and MCP-1 up-regulation in a dose-dependent manner was determined by ELISA.
RAW macrophages pretreatment with free M. tuberculosis mycolic acids and stimulation with TLR-2 agonist
The RAW 264.7 murine macrophage-like cell line (ATCC TIB-71) was cultured and maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco) supplemented with 10% FBS at 37°C in a 5% CO 2 humidified incubator. Macrophage cell number and viability were assessed by trypan blue dye (Gibco) exclusion assay. Before each experiment, 2 9 10 5 cells mL À1 were cultured in 24-well tissue culture plates for 24 h to achieve 70% confluency. Cells were pre-incubated with either varying amounts of mycolic acids (125, 50, 25 ng mL À1 ) or without any mycolic acids at room temperature for 30 min. After the pre-incubation, cells were washed three times with prewarmed DMEM medium to remove excess mycolic acids. Washed cells were incubated with 1 lg mL À1 of the TLR-2 agonist for 72 h. The ability of mycolic acids to block TLR-2-induced TNF-a, IL-12, and MCP-1 up-regulation in a dose-dependent manner was determined by ELISA. An additional experiment was performed in triplicate with RAW macrophage cells with mycolic acids alone to assess immunogenicity.
Statistical analysis
Mean values of triplicate measurements for different cell groups were compared by the Student's t-test.
Results
Production of chemokines by A549 cells infected with M. tuberculosis H37Rv or mce1 mutant
The amounts of chemokines expressed by A549 cells infected with Δmce1 were significantly lower than those in cells infected with the WT or mce1 complemented M. tuberculosis strains. IL-8 and MCP-1 measured in the supernatants of A549 cells infected with the Δmce1 strain were approximately threefold lower than those measured in the supernatants of A549 cells infected with WT strain or complemented strain at 72 h postinfection ( Fig. 1a and b) . Also, the mutant-infected A549 cells produced 1.8 times less IP-10 than the cells infected with WT or the complemented strain (P < 0.04; Fig. 1c ). Similar differences were observed in the amounts of RANTES produced by the A549 cells; mutant-infected cells produced 2.09 times less RAN-TES than cells infected with the WT strain or mce1 complemented strain at 72 h postinfection (P < 0.02; Fig. 1d) . None of the above M. tuberculosis strains (as high as 50 organisms per cell) induced MIP-1a in these experiments (data not shown).
In a different experiment, the induction of chemokines by Δmce1R and Δmce1 mutants in A549 cells was compared. mce1R is the negative regulator of the mce1 operon; M. tuberculosis disrupted in this gene constitutively expresses the mce1 operon genes (Casali et al., 2006) .
Like the mce1 operon mutant, Δmce1R is hypervirulent in mice; it causes accelerated death in mice by inducing massive pro-inflammatory response (Uchida et al., 2007) . WT or Δmce1R-infected A549 cells produced the same amounts of IL-8, while the IL-8 production in Δmce1-infected cells was fourfold lower (Fig. 2a) . Similarly, less MCP-1 was produced in Δmce1-infected A549 cells compared with WT or Δmce1R-infected A549 cells (Fig. 2b) .
Growth of mce1 mutant and control strains in A549 cells
Similar numbers of CFUs were recovered from WT, Δmce1 mutant, or mce1 complemented strain-infected A549 cells from day 0 to the final time point of the experiment, at 72 h postinfection (Fig. 3) . Also, the measurement of live A549 cells with trypan blue exclusion assay indicated that the cell counts in each well were similar. Therefore, these data indicated that the difference in above chemokine production by A549 cells infected with WT or Δmce1 was not due to differences in the number of bacteria in these cells or cell viability.
Involvement of A549 cell TLR-2 in innate immune response to M. tuberculosis infection
The production of IL-8 and MCP-1 was equally diminished in A549 cells that had their TLR-2 blocked before exposure to the WT M. tuberculosis. There was a threefold decrease in IL-8 production when cells were pretreated with anti-TLR-2 antibody prior to the infection with the WT (Fig. 4a) . Similarly, there was a threefold decrease in MCP-1 production when cells were pretreated with anti-TLR-2 prior to the infection with the WT (Fig. 4b) antibody pretreated cells and infected with the Δmce1 produced low concentrations of IL-8 and MCP-1 similar to the cells that were not pretreated with the antibody but were infected with the Δmce1 (Fig. 4a and b) . The production of IL-8 and MCP-1 in A549 cells (pretreated or not pretreated with anti-TLR-2 antibodies) infected with the mce1 complemented strain was comparable to WT-infected A549 cells (Fig. 4a and b) . The ability of anti-TLR-2 antibody to block the TRL-2 binding was confirmed by the low amounts of IL-8 (295 pg mL À1 ) and MCP-1 (176 pg mL À1 ) produced by anti-TLR-2 antibody-treated A549 cells in response to the TLR-2 agonist Pam 3 CysSerLys 4 (Pam 3 Cys; Fig. 4c ). Recovery of CFUs from A549 cells either pretreated or not treated with anti-TLR-2 antibodies was similar (Figs 3 and  4d) .
Effects of interaction between mycolic acids and TLR-2 in A549 cells on innate immune response
Because of the previously reported effects of M. tuberculosis products on macrophage TLR-2-modulated pro-inflammatory response, the macrophage anti-Th1-type immune response that we observed with the mce1 operon mutant (Shimono et al., 2003) , and the excess amounts of unbound mycolic acids in the cell wall of Dmce1 (Cantrell et al., 2013) , we studied the effect of purified mycolic acids on A549 cells. Free mycolic acids diminished the ability of TLR-2 agonist Pam 3 Cys to induce production of IL-8 and MCP-1 in A549 cells in a dose-dependent manner. A459 cells pretreated with 25, 50, and 125 ng mL À1 of mycolic acids produced 1.3, 5.8, and 8.3 times less IL-8 than nontreated cells. Similarly, A549 cells pretreated with 25, 50, and 125 ng mL À1 of mycolic acids produced 2.03, 6.7, and 7.8 times less MCP-1 than nontreated cells (Fig. 5a and b) .
Similar to A549 cells, the response of RAW macrophages to the TLR-2 agonist Pam 3 Cys was also affected by the mycolic acids pretreatment. The effect of pretreatment of RAW macrophages with 25 ng mL À1 of mycolic acids on IL-12, TNF-a, and MCP-1 production was small; that is, the decrease in cytokine or chemokine production between pretreated and nonpretreated was 0.4%, 17.5%, and 3.9%, respectively. However, RAW cells pretreated with 50 ng mL À1 of mycolic acids produced 4.5 times (75.9%), 4.8 times (81.4%), and 4 times (73.3%) less IL-12, TNF-a, and MCP-1, respectively, than untreated cells. RAW macrophages pretreated with 125 ng mL À1 of mycolic acids produced 9.2 times (89.1%), 7.4 times (86.5%), and 14 times (93%) less IL-12, TNF-a, and MCP-1, respectively, than nontreated cells (Fig. 6a-c) .
Discussion
We previously showed that M. tuberculosis disrupted in the mce1 operon proliferates unchecked in BALB/c mouse lungs, but the same pattern of bacterial proliferation was not observed in less susceptible C57BL/6 mice (Lima et al., 2007) . Nevertheless, C57BL/6 mice infected with the Δmce1 succumbed to the infection faster than the WT-infected mice (Lima et al., 2007) . These observations suggested that rather than the bacterial burden, products of the mce1 operon may directly or indirectly modulate the host immune response.
The mce1 operon of M. tuberculosis belongs to a family of four related operons (mce1-4) that have been suggested by phylogenomic analyses to comprise ABC transporters involved in lipid importation (Dassa & Bouige, 2001; Pandey & Sassetti, 2008) . Dunphy et al. (2010) showed that the mce1 operon may serve to recycle mycolic acids released from dying M. tuberculosis inside granulomas. The operon contains a gene fadD5 that encodes fatty acyl-CoA synthetase. They showed that a mutant functionally disrupted in fadD5 is diminished in growth in minimum medium supplied only with mycolic acid as a carbon source; the mutant grew normally in minimum medium supplied with glycerol or other fatty acids as a carbon source (Dunphy et al., 2010) . More recently, we showed that the mce1 operon mutant contained nearly 11-fold more mycolic acids in the cell wall compared with the wild-type H37Rv strain (Cantrell et al., 2013) . The excess mycolic acids were not bound to arabinogalactan or trehalose. The mutant and wild-type strains contained similar amounts of bound mycolic acids. These observations led us to examine the possible role of mycolic acids in the interaction of M. tuberculosis with epithelial cells. Uchida et al. (2007) showed that during the first 4 weeks of infection in mice, the mce1 operon of wild-type M. tuberculosis is not expressed. Indeed, Casali et al. (2006) have shown that the operon is negatively regulated by mce1R, which is active only when M. tuberculosis is intracellular. Thus, during a natural course of infection, wild-type M. tuberculosis may undergo a physiologic state exhibited by the mce1 operon mutant -that is, it may make excess amounts of mycolic acids. mycolic acids, the infection may be eliminated by the contact host at this initial encounter. In this study, we chose A549 cells as the primary cell line to represent early cellular responses to mycolic acids and Δmce1. A549 cells are an immortalized cell line derived from human alveolar epithelial cells, which are represented by type I and II pneumocytes. Much of the surface area of the alveolar space is covered by type I pneumocytes (Castranova et al., 1988) . Type II pneumocytes are more numerous and they synthesize and secrete a variety of surface active products, including surfactant proteins A and D (known as collectins), which play an important role in innate immune protection against pathogens, including against M. tuberculosis (Ferguson et al., 1999; Sano & Kuroki, 2005; Hall-Stoodley et al., 2006; Torrelles et al., 2008) . Thus, alveolar epithelial cells are more likely to serve as the first line of innate defense against inhaled pathogens, even before alveolar macrophages and dendritic cells set in.
Here, we showed that Dmce1 M. tuberculosis and purified mycolic acids can inhibit chemokine and cytokine response in A549 cells as well as in a macrophage-like cell line in a TLR-2-dependent manner. Free mycolates blocked the effect of the TLR-2 agonist Pam 3 Cys. Birchler et al. (2001) have demonstrated that the A549 alveolar epithelial cell line constitutively expresses TLR-2 on its apical surface. Armstrong et al. (2004) detected TLR-2 in situ on alveolar epithelial cells by immunohistochemistry. Thus, it is conceivable that, in vivo, mycolic acids exert an inhibitory effect on alveolar pneumocytes via TLR-2.
The above observations demonstrate the need to better understand the interaction of M. tuberculosis with host cells at a stage much earlier than what is traditionally studied. We also need to better understand the effect on outcomes of infection due to physiologic differences in bacterial populations that serve as the infectious inoculum, rather than assuming that all the bacterial cells exert a similar effect on their target cells once they enter the lungs.
